Results 111 to 120 of about 47,298 (270)

Surgical treatment of myasthenia gravis: 10 years of single center experience

Frontiers in Neurology
ObjectiveTo evaluate a 10-year experience in the surgical treatment of patients with myasthenia gravis, focusing on clinical and pharmacological outcomes.MethodsA retrospective single-center study was conducted based on prospective data collection from ...
José De Sá Moraes Neto, José De Sá Moraes Neto, Jaqueline Schaparini Fonini, Francisco De Assis Cavalcanti Neto, Fernanda Aquino De Oliveira, Gabriel Lunardi Aranha, Antonio Alberto Zambon, Eduardo De Paula Estephan, Edmar Zanoteli, Paulo Manuel Pêgo-Fernandes, Alessandro Wasum Mariani   +10 more
doaj   +1 more source

Immune checkpoint inhibitor‐induced arrhythmias: Mechanistic insights from clinical and preclinical studies

British Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitors (ICIs) have transformed cancer therapy, but their efficacy continues to be limited by immune‐related adverse events. Among these, ICI‐induced cardiac arrhythmias are increasingly recognised as a major adverse reaction, encompassing a broad spectrum of clinical phenotypes, including conduction blocks, atrial fibrillation and
Anand R. Ramalingam, Zoltán Márton Köhler, Péter Ferdinandy, Zoltán V. Varga   +3 more
wiley   +1 more source

Acquired myasthenia gravis in childhood.

, 2010
PURPOSE OF REVIEW: This review discusses recent studies on myasthenia gravis with onset in childhood (juvenile myasthenia gravis) and neonatal myasthenia gravis.
Evoli, Amelia, Amelia Evoli
core   +1 more source

Identifying patients at risk for myasthenic crisis with hemogram and inflammation-related laboratory parameters – a pilot study

Frontiers in Neurology
BackgroundMyasthenia gravis (MG) is a rare autoimmune disease characterized by fatigable weakness of the voluntary muscles and can exacerbate to life-threatening myasthenic crisis (MC), requiring intensive care treatment.
Anne Mehnert, Sivan Bershan, Jil Kollmus-Heege, Lea Gerischer, Lea Gerischer, Meret Luise Herdick, Meret Luise Herdick, Sarah Hoffmann, Sarah Hoffmann, Sophie Lehnerer, Sophie Lehnerer, Sophie Lehnerer, Franziska Scheibe, Frauke Stascheit, Frauke Stascheit, Maike Stein, Maike Stein, Alastair M. Buchan, Alastair M. Buchan, Andreas Meisel, Andreas Meisel, Andreas Meisel, Annette Aigner, Annette Aigner, Philipp Mergenthaler, Philipp Mergenthaler, Philipp Mergenthaler   +26 more
doaj   +1 more source

Effect of Medication Intake on Dental Implant‐Related Outcomes—A Scoping Review

Clinical Oral Implants Research, EarlyView.
ABSTRACT Objective The objective of this scoping review was to evaluate the effect of systemic medications on dental implant outcomes in medically compromised patients. Material and Methods Electronic and manual searches were conducted for this scoping review.
Alberto Monje, Maria Costanza Soldini, Emilio Couso‐Queiruga, Álvaro Babiano, Vivianne Chappuis   +4 more
wiley   +1 more source

Acetylcholine receptor antibody in the diagnosis of myasthenia gravis

, 1983
The acetylcholine receptor (AchR) antibody assay has a key role in the diagnosis of myasthenia gravis. In this article, the role of AchR antibody assay in the diagnosis of ocular and generalized myasthenia gravis is reviewed, and compared to standard ...
Nicholson, G. A., Griffiths, Lyn R., McLeod, J. G.   +2 more
core  

Squamoid Eccrine Ductal Carcinoma: Case Series of a Rare, Potentially Aggressive Skin Cancer Associated With Immunosuppression

Journal of Cutaneous Pathology, EarlyView.
ABSTRACT Squamoid Eccrine Ductal Carcinoma (SEDC) is a rare cutaneous adenexal carcinoma first described in 1997. It has distinct biphasic features on histology which commonly result in misdiagnosis as Bowen disease or cutaneous squamous cell carcinomas (cSCC) if diagnostic skin biopsies are too superficial. This may lead to a delay in diagnosis. It is
Xiang Li Tan, Pooja Patel, Jeva Cernova, Sarah Hogan, Jason Thomson, Efthymios Hadjimichael, Sharanpal Jeetle, Dorota Markiewicz, Michael Sheaff, Nilukshi Wijesuriya, Mark Hawthorne, Graeme Moir, Matthew Stodell, Kapil Bhargava, Suchitra Chinthapalli, Catherine A. Harwood   +15 more
wiley   +1 more source

Myasthenia gravis in children

Magyar nyelvre súlyos izomgyengeségként fordítható myasthenia gravis görög (myasthenia = izomgyengeség) és latin (gravis = súlyos) szavakból tevődik össze, és egy ritka, krónikus neurológiai betegséget jelöl, ami a vázizmok fáradékonyságával és ...
Mostafa, Mousa
core  

Australian clinical practice guideline: diagnosis and treatment of idiopathic multicentric Castleman disease

Internal Medicine Journal, EarlyView.
Abstract Idiopathic multicentric Castleman disease (iMCD) is a rare condition. The pathogenesis is incompletely understood; however, interleukin‐6 (IL‐6) is a major mediator. The clinical presentation is heterogeneous, from mild constitutional symptoms to severe multi‐organ failure.
Dipti Talaulikar, Jun Yen Ng, Adam Bryant, Annmarie Bosco, Hugh C. Caterson, Pratyush Giri, Pravin Hissaria, Simon J. Harrison, Stephen Lade, Connull Leslie, Jacinta Perram, H. Miles Prince, Dejan Radeski, Maureen Rischmueller, Craig Wallington‐Gates, Nicholas Weber, Alberta Hoi   +16 more
wiley   +1 more source

Maintenance intravenous immunoglobulin in chronic inflammatory demyelinating polyneuropathy: trends from an Australian tertiary centre

Internal Medicine Journal, EarlyView.
Abstract Background Chronic inflammatory demyelinating polyneuropathy (CIDP) is commonly treated with long‐term intravenous immunoglobulin (IVIg). Individual dosing requirements and duration of IVIg differ among patients, leading to significant heterogeneity in IVIg utilisation.
Kristina T. Pidd, Anthony Khoo
wiley   +1 more source